drugset / Trial / NCT02457819
Dasotraline Pediatric Extension Study
NaSingle-groupOpen-labelTreatment
Summary
This is an open label 26 week extension study for subjects who completed SEP360-202.
Timeline
- Start
- 2015-06-30
- Primary completion
- 2017-02-02
- Completion
- 2017-02-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dasotraline | Small molecule | 2 mg | — |
| Subject | Dasotraline | Small molecule | 4 mg | — |
| Subject | Dasotraline | Small molecule | 6 mg | — |